HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Actinomyces Gerencseriae

Actinomyces Gerencseriae

Actinomyces gerencseriae, a member of the Actinomyces genus, plays a role in causing infections in humans, with a notable association with cervicofacial actinomycosis. Actinomycosis is a chronic, granulomatous infection characterized by the formation of abscesses and draining sinuses. Actinomyces gerencseriae is recognized for its involvement in this condition, particularly in the cervicofacial region. Cervicofacial actinomycosis caused by Actinomyces gerencseriae often follows a subacute or chronic course, with the potential to mimic other conditions, leading to diagnostic challenges. The infection is characterized by the presence of sulfur granules, which are clumps of bacteria, tissue, and inflammatory debris. Diagnosis involves a combination of clinical evaluation, imaging studies, and microbiological analysis of aspirated material. The treatment of Actinomyces gerencseriae infections typically includes prolonged antibiotic therapy, with penicillin being the drug of choice. In cases of extensive abscess formation, surgical drainage or excision may be necessary. The management of cervicofacial actinomycosis requires a multidisciplinary approach involving infectious disease specialists, surgeons, and other healthcare professionals. While Actinomyces gerencseriae infections are generally responsive to appropriate therapy, the importance of early and accurate diagnosis cannot be overstated. With advancements in diagnostic techniques and a better understanding of the microbiological aspects of actinomycosis, clinicians can improve outcomes and minimize the potential for chronic, debilitating sequelae associated with this bacterial infection.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States
Tags

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp